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Abstract
3D tissue constructs offer a simplified model that mimics the in vivo tissues. Standing post
platform has been established in this study to fabricate 3D tissues with a variety of shapes.
Non-fouling PDMS molds cast from ABS templates were seeded by cell-laden collagen type
I scaffolds. The scaffolds were aggregated to form the tissues within 24 hours. Human
fibroblast, hiPSC-CM, and hiPSC-MSC tissue rings were successfully fabricated with this
standing post platform. Ring contracture of fibroblasts and hiPSC-MSCs was observed and
compared with different collagen density, different cell seeding density, and different cell
culture concentration. In addition, the tissue constructs could also be cultured with serum-free
media. By increasing the number of the standing posts, oval and triangle-shaped hiPSC-MSC
tissue constructs have been also created. Macroscopically morphological changes were
recorded and compared. With these results, the standing post platform was proven its
consistency to fabricate tissue constructs, and ready to be used across different cell types
suitable for quantitative analysis.

Fabrication of 3D tissue constructs using
standing post platform

By
Kantaphon Suddhapas
B.S. Industrial Engineering, Kasetsart University, 2015

Thesis
Submitted in partial fulfillment of the requirements for the degree of
Master of Sciences (M.S.) in Bioengineering

Syracuse University
August 2018

© Copyright 2018 Kantaphon Suddhapas
All rights reserved

Table of Contents
List of Figures ............................................................................................................................ v
List of Tables ............................................................................................................................ vi
1.

Introduction ..................................................................................................................... 1
1.1.

Overview of Tissue Engineering ................................................................................. 1

1.2.

Engineering Tissue Rings............................................................................................ 2

1.2.1.

Muscle Tissue Rings ............................................................................................ 3

1.2.2.

Mesenchymal Stem Cell Tissue Rings ................................................................ 4

1.2.3.

Cardiac Tissue Rings ........................................................................................... 6

1.3.

Human Induced Pluripotent Stem Cell (hiPSC) Technology...................................... 7

1.4.

Goals............................................................................................................................ 9

2.

Methods......................................................................................................................... 10
2.1.

Overview ................................................................................................................... 10

2.2.

PDMS Mold Fabrication ........................................................................................... 11

2.3.

PDMS Mold Coating................................................................................................. 12

2.4.

Cell Culture ............................................................................................................... 12

2.5.

Collagen preparation ................................................................................................. 13

2.6.

Cell Seeding .............................................................................................................. 14

2.7.

Tissue Ring Extraction .............................................................................................. 14

2.8.

Tissue Shape Measurement ....................................................................................... 15

2.9.

Statistics .................................................................................................................... 16

3.

Results ........................................................................................................................... 17
3.1.

Tissue Ring................................................................................................................ 17

3.1.1.

Fibroblast Tissue Rings...................................................................................... 18

3.1.2.

Asymmetrical hiPSC-CM Ring ......................................................................... 20

3.1.3.

hiPSC-MSC Tissue Rings .................................................................................. 21

3.2.

Multi-post hiPSC-MSC 3D tissue structure .............................................................. 27

3.2.1.

2-post hiPSC-MSC structure.............................................................................. 28

3.2.2.

hiPSC-MSC triangle .......................................................................................... 29

4.

Conclusion and Discussion ........................................................................................... 31

5.

Appendix ....................................................................................................................... 36

6.

References ..................................................................................................................... 38

Vita........................................................................................................................................... 45

iv

List of Figures
Figure 1. Scaffold-free tissue ring fabrication protocol ............................................................. 4
Figure 2. Tissue ring and tube fabrication diagram ................................................................... 5
Figure 3. Cardiomyocyte ring fabrication diagram using magnetic .......................................... 7
Figure 4. VSMC ring from modified Gwyther’s protocol ......................................................... 9
Figure 5. Schematic of tissue ring fabrication ......................................................................... 10
Figure 6. Schematic of a ABS mold and its 3D representing image and the corresponding
reversed PDMS mold ............................................................................................................... 11
Figure 7. Images of a mini spoon used to remove PDMS mold, the ABS mold, and the PDMS
mold ......................................................................................................................................... 12
Figure 8. Collagen mixture formula......................................................................................... 13
Figure 9. The probe used for tissue ring extraction ................................................................. 15
Figure 10. Tissue rings measurement ...................................................................................... 15
Figure 11. 2-post system derived tissue shapes measurement. ................................................ 16
Figure 12. 3 and 4- post system derived tissue shapes measurement ...................................... 16
Figure 13. A fibroblast ring comparing to hiPSC-MSC and hiPSC-CM rings ....................... 18
Figure 14. A fibroblast ring from mixing method retaining its shape and size for 14 days .... 18
Figure 15. Fibroblast rings diameter varied by collagen density and fabrication protocol ..... 19
Figure 16. Fibroblast rings thickness and inner diameter ........................................................ 20
Figure 17. A hiPSC-CM ring over 7 days................................................................................ 21
Figure 18. A 0.6 M hiPSC-MSC cells ring turning into a spheroid within 7 days .................. 22
Figure 19. A 0.3 M hiPSC-MSC cells ring turning into a spheroid within 4 days .................. 22
Figure 20. Immunohistochemistry of H&E, CD73, and CD90 ............................................... 23
Figure 21. hiPSC-MSC rings seeded with different collagen density ..................................... 24
Figure 22. hiPSC-MSC rings with 0.3 and 0.6 M cells ........................................................... 25
Figure 23. hiPSC-MSC rings with 0.3 and 0.6 M cells with different serum concentration ... 26
Figure 24. 2-post hiPSC-MSC oval shape and 4-post hiPSC-MSC triangle. .......................... 28
Figure 25. A 2-post hiPSC-MSC tissue shape images ............................................................. 28
Figure 26. 2-post hiPSC-MSC tissue shapes with different post distance gap and deflection
measurements comparison over 13 days.................................................................................. 29
Figure 27. A triangle hiPSC-MSC tissue structure over 13 days. ........................................... 29
Figure 28. hiPSC-MSC triangles with different post system angle, gap, and deflection
measurements comparison over 13 days.................................................................................. 31

v

List of Tables
Table 1. Measurement of fibroblast rings cultured with 2.0 mg/ml collagen density using
mixing protocol in Pluronic-coated wells. ............................................................................... 36
Table 2. Measurement of hiPSC-MSC rings with different collagen density. ........................ 36
Table 3. Measurement of hiPSC-MSC rings with different cell seeding number and serum
concentration. ........................................................................................................................... 36
Table 4. Measurement of hiPSC-MSC triangles...................................................................... 37

vi

1.

Introduction

1.1.

Overview of Tissue Engineering
The goal of tissue engineering is to create native-like tissues by using the combination

of cells, materials, and biological cues1. The technological importance of tissue engineering is
to study human-specific tissue development and diseases in living matters2–4 and to
understand the complexity of biological mechanism on the tissue level5–7. Engineered in vitro
models starts from 2D models, which have great reproducibility but lack of informational
accuracy since native tissues are 3D8. On the other hand, although studies based on living
animals produces physiological information9, it is difficult to quantitatively and consistently
analyze the results to high variation of test subjects. Therefore, 3D tissue models offer us the
opportunities to improve the experimental reproducibility, reduce the cost of animal testing,
test with human cells, and provide the information that is absent in 2D models10,11.
Conventionally, 3D tissue constructs are created by seeding biological cells into the
biomaterial scaffolds fabricated by different methods. The advantages of tissue constructs are
as follows: (1) The constructs can be formed by defined cell compositions, either from
primary cells harvested from human and animals, or from immortal cells lines, such as
fibroblasts (3T3)12–14, endothelial cells (HUVEC)15–17, smooth muscle cells (C2C12)18–20,
etc.; (2) The tissue constructs offer simplified models to investigate fundamental biological
questions, while also can increase the model complexity via different techniques; (3) The
tissue constructs can be used to emulate native developmental processes, such as wound
healing21–23 and muscle development19,24,25; (4) The tissue constructs are readily accessible
for studying tissue mechanics, structure and functions; and (5), The tissue constructs are
reproducible and scalable in both size and quantity26.
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However, tissue constructs also have disadvantages, which needs to be addressed in
many research fields. The tissue constructs are fundamentally different from the native
biological tissues. They are a simplified version of real organ/tissue because the constructs
only contain specific types of cells and lack appropriate cellular interactions occurred in the
native tissues. For instance, although, the majority of cells in hearts are cardiac muscle cells
and fibroblasts that can be recreated in vitro, the incorporation of endothelial cells will need
to be addressed to produce both vascularization and soluble biochemical products that can
impact heart function and development. Moreover, dissimilarity in cell density and
mechanical properties of the tissue constructs and targeted biological tissues can lead to the
functional differences. Currently, one major challenge of tissue engineering is the lack of
supportive infrastructures, such as vascular system, in the tissue constructs, which will result
in insufficient nutrients and oxygen delivery available to the constructs 26.

1.2.

Engineering Tissue Rings
Among all the tissue constructs, ring-shaped tissue constructs offer several advantages

over conventional sheet-shaped tissue constructs: (1); The ring-shaped tissue constructs offer
even force distribution leading to measuring precision since the designs circumvent force
concentration in the center unlike other designs27,28; (2) The ring-shaped tissue constructs are
easier to be handled and sutured to the damaged native tissues with standard clinical
procedures; (3) Specifically for cardiac tissue engineering, the ring-shaped constructs could
potentially be used to mimic the structural feature of ventricular tissue sections for further
analysis on contractile behaviors in a biomimetic manner. A network of ring-shaped
constructs could be used to emulate human organs, such as vasculature and trachea, since a
ring-shaped tissue could mimic the cross section of these organs for understanding their
physiological and mechanical functions.
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1.2.1. Muscle Tissue Rings
Coronary artery bypass grafting surgery (CABG), a surgery aiming to restore normal
blood flow by replacing a problematic section of an artery, is performed hundreds of
thousands of times yearly in United States29–31. One in three patients is not suitable for
autologous surgery because of the lack of available artery32. Vascular tissue engineering is a
way to help these patients by fabricating such an artery. Vascular tissue engineering also may
provide a suitable model for studying heart diseases. Scaffold-free tissue ring fabrication has
been presented for vascular tissue engineering32. In summary, the protocol is as follow: (1)
Polycarbonate template is created by traditional milling process; (2) Polydimethylsiloxane
(PDMS) mold is fabricated by adding the polymer at a ratio of (10:1) (w/w) into the
polycarbonate template. The PDMS mold will be ready after curing at 60°C for 4 hours; (3)
Agarose mold is cast using the PDMS mold; (4) cells are seeded into the agarose mold; (5)
Media is exchanged every other day beginning from 24 hours after the seeding; (6) A
consistent ring should be formed within 7 days. The protocol is illustrated in Figure 1.
This protocol can be used with various types of cells, such as rat smooth muscle cells
(rSMCs) and human smooth muscle cells (hSMCs) by adjusting the protocol. The tissue rings
with different cells resulted in different morphology, matrix composition, and mechanical
properties. By performing tensile strength testing, they found Day-14 0.66 million rSMCs
rings were stronger and thicker than Day-7 0.5 million rSMCs rings and Day-14 0.75 million
hSMCs rings (97 ± 30 vs 113 ± 8 vs 160 ± 30 kPa for UTS (ultimate tensile strength) and
0.94 ± 12 vs 0.53 ± 0.02 vs 0.51 ± 0.05 mm for thickness). hMSCs rings were fabricated
and broken during initial pre-cycling phases of uniaxial tensile testing due to the lack of
mechanical strength. However, the protocol possesses several drawbacks: (1) the method
depends largely on the operator; (2) the agarose mold is not reusable, so each cell seeding
requires additional fabrication process of agarose molds from PDMS molds.
3

Figure 1. Scaffold-free tissue ring fabrication protocol32. (A) Schematic of fabrication
method, (B) Polycarbonate mold with 2 mm pole; scale bar = 6 mm, (C) PDMS template
after casting; scale bar = 6 mm (D) Agarose well with tissue ring; scale bar = 6 mm, (E) A
tissue ring in PBS; scale bar = 2 mm
1.2.2. Mesenchymal Stem Cell Tissue Rings
Mesenchymal stem cells (MSCs) are immune-evasive multipotent stromal stem
cells33. MSCs can be acquired from sources such as bone marrow, cord cells, adipose tissue,
molar cells, etc. MSCs can give rise to many lineages such as bone, fat, chondrocyte, muscle,
neuron, islet cells, and liver cells34. Because of harvest and differentiation potentials, MSCs
offer a bright future, but studies need to be performed before using them clinically, especially
studying on differentiation pathway and immune modulation.
MSCs are also located at perivascular locations surrounding blood vessels (on both
arterial and venous vessels) in the bone marrow35, thus 3D MSC tissue ring and tube might be
4

suitable to mimic native morphology and behavior in vitro. Additionally, hMSC-derived
cartilaginous tissue rings were fabricated with the final goal of creating tissue tubes with
multiple rings36. The fabrication protocol was improved by the agarose devices for increasing
throughput of tissue rings from one single mold. The cells were seed with TGFβ-loaded
microspheres to fabricate the hMSC rings as depicted in Figure 2. The microspheres helped
to produce thicker and darker hMSC tissue rings than their counterpart as shown in Figure 3.
In the mechanical testing, hMSC and hMSC + microspheres tissue tubes had equal and higher
maximum load and tensile strength compared to the native rat trachea.

Figure 2. Tissue ring and tube fabrication diagram36. hMSCs + growth factor loaded
microsphere were loaded into agarose wells. The rings were taken out on day 2 to
manufacture tissue tubes by stacking tissue rings on silicon tubes. (A) hMSCs rings and (C)
hMSCs + microsphere rings were in agarose well outlined by white dots with 2 mm post
outlined by black dots. (D) hMSCs tubes and (D) hMSCs + microsphere tubes were produced
by stacking 3 rings (white arrow) and 6 rings (black arrow) on silicon tubes
5

1.2.3. Cardiac Tissue Rings
Cardiac tissue cells or cardiomyocytes are the muscle cells of the cardiac muscles.
The cells are paramount to unison contraction mechanism to deliver blood to various organs
and tissues. The inability of cardiomyocytes to proliferate after birth is an obstacle to cardiac
tissue repairs, thus cardiomyocytes are required to be derived from stem cells for cell
transplantation. To observe cardiac tissue functions in vitro, 3D engineered cardiac tissue is
to fabricate cardiac tissue for a specific part of the heart. For example, decellularized heart
tissue has been executed by decellularizing whole heart and filling them with
cardiomyocytes. The decellularization leaves ECM intact including blood vessel and
connective tissue and eliminates cells. This method presents alternative autologous heart
transplantation37. Another example is prefabricated matrices method referred to as a protocol
which seeding cells into prefabricated porous solid matrices. The matrices can be
manipulated to desired geometry such as cardiac sheet for repairing damaged heart and
cardiac tissue ring to study biological questions38.
Akiyama et al. have developed the cardiac tissue ring fabrication method and
introduced the concept of seeding cardiomyocytes with magnetic particles39. This method
used polycarbonate pole, instead of conventional PDMS or agarose mold, as illustrated in
Figure 3. The method begins with mixing suspended cardiomyocytes in medium containing
MCL magnetic particles (Fe3 O4 ; average particle size of 10nm). After that, the MCL labeledcardiomyocytes are mixed with collagen solution. The mixture is cast into the well with
polycarbonate pole in the center. Then, the cardiomyocytes are accumulated onto culture
bottom by placing a magnet beneath the well to attract the MCL- labeled cardiomyocytes.
The cardiomyocytes layer will be formed. Excess ECM are to be aspirated before incubating
the remaining cardiomyocytes for an hour after which media are added. The cardiomyocyte
layer will rapidly shrink into a cardiac tissue ring within 3-5 days. The results suggested that
6

80% cell viability at 200 MCL pg/cell. Contractile forces were observed by inducing
electrical pulses on the cardiac tissue ring. The replicability of the method is excellent, but
the tissue fabricated by this method has foreign magnetic particles embedded throughout the
tissue preventing usages in drug discovery and tissue replacement.

Figure 3. Cardiomyocyte ring fabrication diagram using magnetic39. a mixture of MCLlabeled cardiomyocytes and ECM precursor were seeded into a well with polycarbonate post.
After that immediately, cardiomyocytes were attracted to the well bottom by placing a
magnet under the well forming cardiomyocytes layer. Excess ECM were to be aspirated
before adding the medium. Rapid shrinkage of cardiomyocytes sheet was occurred resulting
in cardiomyocyte tissue ring
1.3.

Human Induced Pluripotent Stem Cell (hiPSC) Technology
Induced pluripotent stem cells (iPSCs) are pluripotent stem cells derived from animal

and human somatic cells by reprogramming using four factors; Oct4, Sox2, Klf4, and c–Myc.
iPSCs were introduced in 2006 and rejuvenated the stem cell field since previously the only
pluripotent stem cells available to researchers were embryonic stem cells (ESCs) that are
highly controversial in ethics40. The iPSCs have differentiation potential to any cell types,
which makes them a precious tool for stem cell research and regenerative medicine.
Combining hiPSC technology and tissue engineering method, mimicking native tissue with
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higher accuracy could be achieved. hiPSCs-derived tissue rings have been developed for
engineering vascular and perivascular tissues in vitro.
In 2016, Dash et al. have experimented on tissue-engineered vascular ring41. The team
used improved Dikina-modified Gwyther’s method36, a scaffold-free tissue ring fabrication
method. Briefly, hiPSC-derived vascular smooth muscle cells (hiPSC-VSMCs) were seeded
into ring-shaped agarose well and formed tissue rings within a day after the seeding.
Thinning and failure of the rings have been observed under the rings cultured with SmGM-2
within 4 to 7 days, however, the problem was solved when switching media to culture
medium with 20% FBS, PDGF-BB, and TGF-β1 one day after seeding. A large amount of
collagen type I was present in the rings. The average thickness was 0.84 – 0.87 mm with the
inner diameter of 2 mm at day 14 – 17. The stress-strain plot was drawn in Figure 4(a).
Contractility measurement was calculated by using force required to move a ring by a
distance of 1.14 mm divided by its cross-sectional areas (Figure 4(b)). 1 mM carbachol and
50 mM KCl were added as an agonist to observe contractility reaction and the results were
67.35 ± 22.7 Pa and 44.44 ± 27.13 Pa respectively for different drugs (Figure 4(c)).
Additionally, supravalvular aortic stenosis (SVAS) hiPSC-VSMCs have been generated by
the same protocol. Contractility of control hiPSC-VSMCSs in response to carbachol was
much higher than the disease hiPSC-VSMCs (42.01 ± 11.77 Pa and 5.51 ± 4.51 Pa
respectively) (Figure 4(d)).
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Figure 4. VSMC ring from modified Gwyther’s protocol41. The top left image depicted
the VSMC ring during the measurement (a). Stress & Strain were plotted (b). hiPSCVSMCs contractility in response to agonists; carbochol and KCl (c). Healthy and diseased
VSMC rings were compared, showing the healthy ones were stronger (d).
1.4.

Goals

This study has 3 objectives: (1) Develop a protocol to generate tissue rings from several cell
types (human fibroblast, hiPSC-derived MSC and hiPSC-derived cardiomyocytes); (2)
Generate hiPSC-derived MSC tissue ring with chemical-defined culture media and achieve
geometrical consistency and high reproducibility; (3) Create a variety of tissue shapes with a
multi-posts system.

9

2.

Methods

2.1.

Overview
Figure 5 illustrated tissue ring fabrication protocol. Acrylonitrile butadiene styrene

(ABS) molds were printed by a 3D printer. PDMS molds were created by using ABS molds
to be a container for the cells suspension in collagen type I matrix with the expectation that
cells would aggregate surrounding the post.

Figure 5. Schematic of tissue ring fabrication. (1) Printing ABS mold (scale bar = 3mm),
(2) Casting PDMS mold (scale bar = 3mm) from ABS mold, (3) seeding cells with collagen
into the PDMS mold (scale bar = 1mm), and (4) tissue rings aggregated within a day (scale
bar = 1mm) were illustrated.

Different ABS molds could be designed to produce smaller tissue rings or multi-post
system to produce 3D tissue structure such as triangle or ellipse. 2-post, 3-post, and 4-post
molds were fabricated based on this concept. PDMS and curing agent ratio were used as 10:1
for tissue ring formation but increased to 5:1 to accommodate the multi-post system. The
total amount of cell suspension mixture was adjusted linearly based on the volume of the
PDMS molds. For instance, a 2-post PDMS mold was required a double amount of cells
suspension mixture of a regular ring-shape PDMS mold.
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2.2.

PDMS Mold Fabrication

Figure 6. Schematic of a ABS mold (a) and its 3D representing image (b) and the
corresponding reversed PDMS mold (c).
The ABS molds were designed using SolidWork, saved into STL files, and printed
using MakerBot Replicator 2X 3D printer. The PDMS molds were designed to fit in the cell
culture wells of the regular 24-well plate (21 mm in diameter). To fabricate PDMS molds
with 3 mm trough and 2 mm center post designed in Figure 6, ABS molds were coated with
silicone spray (stoner, G0093241) to help with PDMS detachment. PDMS and curing agent
were mixed at a ratio of 10:1 (w/w) in weighing boat and poured into ABS molds. The molds
containing PDMS were then transferred into a desiccator connecting to a vacuum pump and
degassed for 3 hours to remove all bubbles that would negatively affect PDMS consistency.
Next, the PDMS was cured in an oven at 60°C overnight.
To take the PDMS molds out of the ABS molds, the edge between the solidified
PDMS and the ABS mold was traced with an X-ACTO knife gently. The PDMS molds were
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removed by using a mini spoon depicted in Figure 7. Finally, the PDMS molds were rinsed in
70% Ethanol for 15 minutes for sterilization.

Figure 7. Images of a mini spoon (a) used to remove PDMS mold, the ABS mold (b), and
the PDMS mold (c).
2.3.

PDMS Mold Coating
The Pluronic solution was used to coat PDMS molds to have a non-fouling surface.

10% Pluronic acid was made by adding 1g of Pluronic F-127 (Pluronic® F-127, P2443) in 10
mL of distilled water and dissolving in the oven at 50°C overnight. Then, the 10% Pluronic
acid was sterilized using Steriflip® Filter Unit and stored at room temperature. Before
coating PDMS molds, the PDMS molds were washed with 70% Ethanol and PBS solution
respectively. To coat the molds, 10% Pluronic acid was poured into the molds and incubated
for 24 hours at room temperature.

2.4.

Cell Culture
Human fibroblast cells were cultured in low glucose DMEM supplemented with 10%

fetal bovine serum (v/v) (Thermofisher, 10437010), 1% Glutamax (Thermofisher,
35050061), and 1% Nonessential Amino Acids (Thermofisher, 11140076) and maintained at
37 °C in a 5% CO2 incubator. Passaging was performed approximately every week using
Trypsin-EDTA (Thermofisher, 25200114) at 37 °C for 5 minutes to dissociate the cells and
then transferred 10-15% cells available into each new culture flask with the same size.
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hiPSC-MSCs were received from Tackla Winston. hiPSC-MSCs were maintained in
serum-free StemPro MSC medium (Life technologies, A103320) at 37 °C in a 5% CO2
incubator. Passaging was performed approximately every week using Trypsin-EDTA
(Thermofisher, 25200114) at 37 °C for 5 minutes to dissociate the cells and then transferred
10-15% cells available into each new culture flask with the same size. hiPSC-CMs were
received from Chenyan Wang. hiPSC-CMs were maintained in RPMI media supplemented
with B-27 complete.

2.5.

Collagen preparation
Collagen scaffold was prepared by the combination of rat tail Collagen I

(Thermofisher, A1048301), 1N NaOH (Sigma-Aldrich, 1091371000), distilled water, and
10X PBS (Thermofisher, AM9625) according to manufacturer’s instruction.

Figure 8. Collagen mixture formula. Collagen, 10X PBS, 1N NaOH, and distilled water
were used according to the calculation.
Since collagen rapidly gels at room temperature, other reagents needed to be mixed in
advance before mixing with collagen. For instance, to produce 2 mg/ml collagen mixture for
100 µl, 66.67 µl of 3 mg/ml rat tail collagen I, 10 µl of 10X PVS, 1.67 µl of 1N NaOH, and
21.67 µl of distilled water were needed. NaOH, 10X PBS, and distilled water were loaded
and mixed into a tube. When cell-suspension media was ready, the collagen was then added
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into the same tube. 200 µl pipette tips or larger were recommended, otherwise, the procedure
should be done on ice to avoid collagen being clogged inside the tips.

2.6.

Cell Seeding
Cells from culture flask were trypsinized for 5 minutes in the incubator at 37 °C with

5% CO2, the cell-suspension media was transported into a tube, and then cell culture media
was added to the tube. Centrifuge was conducted to let cells form a pellet on the bottom. The
supernatant was aspirated, and the cells were evenly distributed by adding new media. Cell
counting was executed using hemocytometer. Cell-suspension media was adjusted to the
desired concentration. For instance, to change the 2 ml cell suspension with 5 million (5 M)
cells into the final cell concentration of 0.3 M cells per 50 µl, the media would be decreased
to (5 M/ 0.3 M) x 50 µl = 833.33 µl. The media would be pelleted, subsequence supernatant
would be aspirated, and 833.33 µl of media would be added. After adjusting, the cell
suspension media was added into prepared collagen mixture with a ratio of 1:2. The cellcollagen mixture was loaded into PDMS wells and incubated at 37 °C with 5% CO2 for 40
minutes, and then media was filled to the top of the wells. The media were changed every 2
days.

2.7.

Tissue Ring Extraction
Tissue rings could be extracted out of the PDMS wells when they became strong

enough for the extraction. Fibroblast tissue rings were extracted on day 1, hiPSC-MSCs were
extracted on day 3 for DMEM + 10% FBS and serum-free culture media, but on day 7 for
DMEM + 5% FBS. hiPSC-CM rings were resilient enough on day 7, but they were strongly
attached to the posts, resulting in difficulties for the extraction. To extract tissue rings, mini
probe, shown in Figure 9, was used to push the ring up gently to the top of the posts.
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Figure 9. The probe used for tissue ring extraction.
2.8.

Tissue Shape Measurement
The microscopic images were captured using either 1 frame (tissue rings) or 4x4

frames (tissue constructs) to cover the entire tissues. The tissue rings were measured at least 3
times stochastically for thickness, inner diameter, and ring diameter, as shown in Figure 10,
by Nikon Eclipse Ti microscope and NIS Elements software. The measurements were then
averaged for each sample.

Figure 10. Tissue rings measurement. The tissue ring thickness and inner diameter were
measured.
2-post 3D tissue constructs were measured for the gap between a post and the
structure, and deflection of the structure (D) defined direction toward the structure as positive
as depicted in Figure 11.
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Figure 11. 2-post system derived tissue shapes measurement. The gap between the post
and the structure (G) and the deflection of the structure (D) were measured.
3D triangle tissue constructs were measured for the gap between a post and the
structure (G), the angle between the center line and the direction of the gap (Angle), and
deflection (D) of the structure as shown in Figure 12. Each value was also normalized by
dividing the value by the distance between posts.

Figure 12. 3 and 4- post system derived tissue shapes measurement. The gap between
post and the structure (G), the angle of the gap (Angle), and the deflection on each side (D)
were measured.
2.9.

Statistics

Each batch was analyzed with a sample size of at least 3 sample per group. The data were
represented as means ± standard deviation. Prism 6 software (version 6.01) was used to plot
and perform one-way and two-way ANOVA with p-value < 0.05 considered significant.
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3.

Results

3.1.

Tissue Ring

Previous studies had reported deriving tissue rings from scaffold-free method32,41. However,
the reports also stated the significance of cell aggregation. Dash et al. were switched to
collagen-promoting supplemented media, otherwise hiPSC-VSMC were failed to hold its ring
structure within 4-7 days. This highlighted the importance of scaffold, especially collagen, to
form a solid tissue ring. Collagen had been selected to act as a scaffold, as it is abundant in
ECM. To seed with collagen, a container was needed to enforce collagen to retain the desired
shape. PDMS well with a center post would be appropriate to accomplish the task. PDMS
was our material of choice of the well because of its inert, non-toxic, reusable and clear. 3D
printed ABS mold negative was fabricated to be used as a primary mold to manufacture
PDMS mold. Nevertheless, a combination of the collagen-cell mixture in a PDMS mold was
not enough to produce a tissue ring, because collagen and cells attached to the mold surface
subsequently unsuccessful to aggregate to the center and form a ring. Pluronic F127 was
introduced to remedy the problem by coating the mold to induce non-fouling surface on the
mold surfaces. Fibroblasts were the first cells to be experimented to polish seeding protocol
due to their robust nature. hiPSC-MSCs and hiPSC-CMs were later seeded by using the
established protocol. Fibroblast, hiPSC-MSC, and hiPSC-CMs tissue rings could be seen in
comparison in Figure 13.
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3.1.1. Fibroblast Tissue Rings
Experiments were completed using 0.5 M cells for each condition. Two collagen
concentrations had been applied (0.5 and 2.0 mg/ml) to form the fibroblast tissue rings. To
study the effect of the non-fouling surface on PDMS surface, cells were seeded into the wells
with and without Pluronic acid coating. Each ring had been observed for a period of 14 days
as shown in Figure 14.

Figure 13. A fibroblast ring (a) comparing to hiPSC-MSC (b) and hiPSC-CM (c) rings
(scale = 1 mm).

Figure 14. A fibroblast ring from mixing method retaining its shape and size for 14 days
(scale bar = 1 mm).
We found higher collagen concentration yielded no significant difference in ring
diameter with p-value = 0.1281 at Day 14 (Figure 15(a)). The average ring diameters of 0.5
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and 2.0 mg/ml were 2.382 ± 0.687 and 3.282 ± 0.398 mm. The results suggested seeding
with 2.0 mg/ml collagen would offer thicker tissue ring.
Shaking and mixing protocols were introduced to establish consistent rings. Pluronic
acid was added to detach the collagen gel from the PDMS mold. The seeded wells with
shaking protocol were shaken for 600 RPM x 3 minutes using Labnet Vortemp 56 EVC
Shaking Incubator. Comparing to the shaking protocol, mixing protocols described in the
method section were resulted in larger and consistent rings as shown by the mean and
standard deviation, shown in Figure 15(b). The results didn’t conclude any significant
differences between each group in diameter except shaking and pluronic + mixing with pvalue = 0.0076. The ring diameters of control, shaking, Pluronic+ shaking, and Pluronic +
mixing groups were 3.282 ± 0.398, 2.691 ± 0.367, 3.062 ± 0.371, and 3.518 ± 0.057 mm.

Figure 15. Fibroblast rings diameter varied by collagen density and fabrication
protocol. The top left graph depicted ring diameter varying collagen concentration (a). The
top right graph depicted the effect of Pluronic acid coating on the ring diameter (b). The
bottom graphs showed the fibroblast rings seeded in Pluronic coated well using mixing
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protocol and 2.0 mg/ml collagen over time and on the last day (c and d). The rings were
measured on day 14.
Fibroblast tissue rings fabricated from mixing protocols were characterized in detail
in Figure 15(c), 15(d) and Figure 16. The rings retained size and shape consistently
throughout two-week culture after the first 2 days, therefore the protocol was finalized to be
performed for seeding hiPSC-MSCs and hiPSC-CMs.

Figure 16. Fibroblast rings thickness (a) and inner diameter (b). The rings retained the
openness over time.
3.1.2. Asymmetrical hiPSC-CM Ring
1 M hiPSC-CMs were seeded in each asymmetrical well to fabricate an asymmetrical
cardiac ring imitating ventricular tissue as shown in Figure 17. Seeding with 0.3 and 0.6 M
cells were also performed previously, but resulting in failure; cells were not able to aggregate
into a ring. The hiPSC-CM rings were able to beat within 4 days without using any stimulant.
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Figure 17. A hiPSC-CM ring over 7 days. The ring had uneven surface unlike other cell
types (scale = 1 mm).
3.1.3. hiPSC-MSC Tissue Rings
hiPSC-MSC rings fabricated using mixing protocol with Pluronic coating were
resulted in an unexpected occurrence that the rings became solid structure (closing inner
diameter), 2-4 days after removing from the molds at Day 3, depicted in Figure 18-19. This
phenomenon was not reported from Dikana et al MSC rings fabricated using the scaffold-free
method, because their rings remained in the molds and were harvested right before the
measurement. They didn’t characterize the ring growth and morphogenetic changes after
removal from the devices.
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Figure 18. A 0.6 M hiPSC-MSC cells ring turning into a spheroid within 7 days. The ring
was removed from the PDMS mold on day 3 cultured with DMEM + 10% FBS (scale bar =
1mm).

Figure 19. A 0.3 M hiPSC-MSC cells ring turning into a spheroid within 4 days. The ring
was removed from the PDMS mold on day 3 (scale bar = 1mm).
Histochemistry was performed immediately after the rings were extracted from the
molds, showing positive MSC biomarkers of CD 90 and CD 73 and H&E staining, as
illustrated in Figure 20.
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Figure 20. Immunohistochemistry of H&E, CD73, and CD90. The top left (a) and the
bottom left (c) pictures depicted expression of CD 90. The top right (b) was the result of
H&E staining. The bottom right (d) exhibited a hiPSC-MSC ring expressing CD73.
hiPSC-MSC rings were seeded in two total amounts of cells (0.3 and 0.6 M cells),
three different collagen concentrations (0.5, 1.0, and 2.0 mg/ml) and cultured with different
serum concentration (5% FBS and 10% FBS) and serum-free media. The rings were
harvested on day 3, except 5% FBS groups harvested on day 7, because of insufficient
strength to be removed from the mold in earlier days.
Collagen concentration study had been depicted in Figure 21. In summary, collagen
concentration affected thickness significantly (p-value = 0.0011) with significant difference
between 0.5 and 1.0 mg/ml groups (p-value = 0.0008). Collagen concentration also
influenced inner diameter significantly (p-value = 0.0032) with significant differences
between 0.5 and 2.0 mg/ml groups (p-value = 0.0192), and 1.0 and 2.0 mg/ml groups (pvalue = 0.0028). Lastly, collagen concentration impacted ring diameter (p-value = 0.0004)
significant with significant differences among every 2 groups; 0.5 and 1.0 mg/ml (p-value =
0.00283), 0.5 and 2.0 mg/ml (p-value = 0.0003), and 1.0 and 2.0mg/ml (p-value = 0.0304).
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The data was also summarized in Table 2. Contrast to the Fibroblast rings which became
thicker when seeding with higher collagen concentration, the hiPSC-MSC rings were thicker
with lower collagen concentration.

Figure 21. hiPSC-MSC rings seeded with different collagen density. The rings with 0.5
,1.0, and 2.0 mg/ml were resulted in different thickness (a), inner diameter (b), and ring
diameter (c).
The effect of cell number has been investigated in Figure 22. hiPSC-MSC rings were
seeded with two different amounts (0.3 and 0.6 M cells). Both types of the hiPSC-MSC rings
showed a similar trend in thickness, inner diameter, and ring diameter over time (Figure
22(a), 22(c), 22(e)). Thickness was drastically increased right after the rings were removed
and gradually declined over time. Inner diameter was rapidly declined after the removal and
reach to zero within 7 days for 0.6 M cells and 11 days for 0.3 M cells. Ring diameter was
gradually shrinking at a different rate for each system over time corresponding to inner
diameter shrinkage. However, the rings after the removal on day 3 depicted in a different
manner. Although the two systems showed no significant difference in thickness (p-value =
0.5131), they had the difference on inner diameter with p-value = 0.0250 and ring diameter
with p-value = 0.0077. The data was shown in Table 3.
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Figure 22. hiPSC-MSC rings with 0.3 and 0.6 M cells. The thickness, the inner diameter,
and the ring diameter of each cell number were shown over 11 days ((a), (c), (e)) and were
plotted on day 3 on Figure ((b), (d), (f)).
hiPSC-MSC rings with 0.3 M and 0.6 M cells were cultured with two different FBS
concentrations (5.0% and 10.0%) and serum-free media to inspect the effect of different
culture media (Figure 23). Culture media had no significant effect on thickness for both 0.3
M (p-value = 0.2749) and 0.6 M cells (p-value = 0.4771) (Figure 23(a) and 23(b)). However,
this did not apply to inner diameter as shown in Figure 23(c) and 23(d) (p-value = 0.0003 for
0.3 M cells and p-value = 0.0304 for 0.6 M cells). For the hiPSC-MSC rings with 0.3 M cells,
the statistical difference on inner diameter between 10% and 5% FBS had p-value of 0.0007,
between 5% FBS and serum-free media had p-value of 0.0010. The tissue rings seeded with
0.6 M cells only showed significant difference between 10% FBS and serum-free media
groups with p-value of 0.0024. For ring diameter differences, 0.6 M cells were resulted in no
significant difference (p-value = 0.2771) but 0.3 M cells had demonstrated significant
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difference with p-value < 0.0001 with significant differences between 5.0% FBS to 10.0%
FBS and serum-free media of p-value < 0.0001 for both comparisons (Figure 23(e) and
23(f)).

Figure 23. hiPSC-MSC rings with 0.3 and 0.6 M cells with different serum
concentration. The rings cultured with 10% FBS, 5%FBS, and Serum free were plotted
showing the thickness, the inner diameter, and the ring diameter over 11 days ((a), (c), (e))
and upon removal ((b), (d), (f)) (day 3 for 10%FBS and serum-free media and day 7 for
5%FBS).
Two-way ANOVA was performed comparing the effect of a number of cells seeded
and serum concentration to thickness, inner diameter, and ring diameter. The result showed
no significant differences caused by a number of cells seeded, serum concentration, and their
interaction affecting thickness. On the other hand, significant differences in inner diameter
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caused by serum concentration (p-value = 0.0055) and the interaction between a number of
cells seeded and serum concentration (p-value = 0.0071) were present. Finally, ring diameter
was not influenced by a number of cells seeded or serum concentration but influenced by the
interaction of the two factors with a p-value of 0.0179.

3.2.

Multi-post hiPSC-MSC 3D tissue structure
Mechanical stimuli were known factor affecting cell behavior. Microscopically, the

mechanical stimuli maintain and regulate chondrocyte phenotype42. Macroscopically, the
tissue structure could be remodeled. To understand the importance of mechanical stimuli, a
model was needed. Our multi-post system could serve as a tool to pursue the question. The
number of the post could be modified to provide a different kind of forces. In addition,
hydrogel could be changed or modified to observe the interaction between the hydrogel and
mechanical stimuli.
2-post system was used to represent the simple model, in which only bidirectional
forces were presented to regulate the tissue morphology and structure. Tissue triangles
represented a more complex model, in which forces were presented from several directions.
The center post of the tissue triangles could be served as a stabilizer offering more evenlydistributed forces comparing to the triangles without the center post. The deflection and the
gap of the structure had been chosen as parameters to be measured, because of their
observability. These parameters could be compared under different tissue geometries and
culture conditions to understand the role of mechanical forces on tissue remodeling.
Multi-post hiPSC-MSC 3D structures were fabricated using the same protocol as
previous tissue rings by linearly increasing required cell suspension volume (Figure 24).
Despite fabricating them with identical protocol, the gap between tissue and posts in 2-post
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system was narrowing, while the gap in triangle posts was widening. In following
experiments, three multi-post systems (2, 3, and 4 posts) had been performed.

Figure 24. 2-post hiPSC-MSC oval shape and 4-post hiPSC-MSC triangle; Day-4 hiPSCMSC 2-post structure was shown in the figure a (the distance between the post was 4 mm)
and day-5 hiPSC-MSC 4-post triangle was shown in figure b (the triangle was equilateral
with 8 mm on each side and the center post point of origin was at the center of the triangle)
(scale bar = 1 mm).
3.2.1. 2-post hiPSC-MSC structure
2-post hiPSC-MSC structures with 5 and 6 mm post distances had shown no
significant differences. Deflection was gradually increasing, while the gap was decreasing in
the same manner over time (Figure 25 and 26).

Figure 25. A 2-post hiPSC-MSC tissue shape images over 13 days (scale bar = 1mm).
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Figure 26. 2-post hiPSC-MSC tissue shapes with different post distance gap and
deflection measurements comparison over 13 days; Gap (a) and deflection (b) of 5 and 6
mm post distance 2-post hiPSC-MSC tissue shapes portrayed no significant differences over
time.
3.2.2. hiPSC-MSC triangle
hiPSC-MSC triangles seeded in 6 mm, 8 mm with and without center post were
experimented to study the effect of the center post and the post distance on the tissue
remodeling (Figure 27 and Table 4).

Figure 27. A triangle hiPSC-MSC tissue structure over 13 days. (scale bar = 1mm).
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The gap was influenced by both the center post and the post distance with the
significance of p-value = 0.0041 (Figure 28(a), 28(b)). The normalized gap between 6 and 8
mm without the center post, which could indicate the importance of the post distance, was
found significantly different with the p-value of 0.0069 (0.234 ± 0.032 and 0.313 ± 0.021
mm). The normalized gap between with and without the center post (same 8 mm post
distance), which could indicate the importance of the center post, was found significantly
different with the p-value of 0.0054 (0.222 ± 0.031 and 0.313 ± 0.021 mm).
Deflection was only impacted by the post distance since the existence of the center
post did not affect the deflection as supported by Figure 28(c) and 28(d), which indicated no
significant difference between 8mm hiPSC-MSC structure with and without the center post.
However, the post distance influenced the deflection, since 6 mm without the center post was
the difference to 8 mm with and without the center post indicated by the p-value of 0.0143
and 0.0180 (0.064 ± 0.021, 0.108 ± 0.024, and 0.110 ± 0.010 mm respectively).
Angle was not determined differently by either the presence of the center post or the
distance between the posts as shown in Figure 28(e) and 28(f).
Comparing the tissue remodeling characteristics between 2-post structures and
triangle structures, the gap displayed in opposite manner, which showed that the gap of the
triangles was increasing over time, while the gap of 2-post structures was decreasing over
time. Yet, the deflection was increasing over time in both systems. Clearly, the mechanism
behind the disparity could be further studied by expanding the experiment.
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Figure 28. hiPSC-MSC triangles with different post system angle, gap, and deflection
measurements comparison over 13 days. The hiPSC-MSC triangles with 6 mm without
center post, 8 mm with and without center post were measured for normalized gap,
normalized deflection, and angle over the duration of 13 days ((a), (c), (e)) and on day 13
((b), (d), (f)).

4.

Conclusion and Discussion
A protocol for tissue ring fabrication that can be applied to several cell types

had been created. The protocol can be improved by minimizing tissue ring size to serve as an
economically sound test sample for drug discovery research. One way to achieve this is to
reduce the size of the mold. This, in turn, could bring problem concerning cell seeding, since
the high viscosity of collagen gel would make it challenging to use smaller pipette tips lesser
than 200 µl. Another aspect of minimizing tissue ring was the consistency. Ring cultured
with a third size of normal tissue ring with 2mm diameter had been performed resulting in
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geometrically inconsistent rings (data not shown). Lastly, the mold could be put together in a
productive manner by creating a block featuring numerous wells within the block.
Contracture in hiPSC-MSC and fibroblast rings after the removal was also observed
in fibroblasts with free-floating collagen model43,44. Briefly, the cell-laden collagen scaffold
was seeded and detached from the well to observe its contracture over time, which was
exhibited inclusively when using collagen as a scaffold44. The free-floating fibroblastcollagen was contracting into a ball, but our fibroblast rings were contracting for 3 days after
the removal and retained their morphology. Given that fibroblast could acquire myofibroblast
phenotype under mechanical tension45, the situation with the fibroblast rings might be
because fibroblasts differentiated into myofibroblasts that induced by the external force from
the center post. If that was the case, the model could be used to study the importance of α-SM
actin in myofibroblast to fibroblast differentiation which was not answered yet45.
Tissue contracture was also correlated with various cytokines. Extracellular matrix
metalloproteinase inducer (EMMPRIN) expression increased the contractile properties in
fibroblasts and α-SM actin production, which was a marker of myofibroblasts45.
Transforming growth factor β (TGF-β) also induced contracture in fibroblast45, increased
EMMPRIN output46, and enhanced rings strength36. Finally, IL (interleukin) 4 and 13
prompted MSC-laden collagen type I gel contracture47. In future, supplementing these
cytokines in culture media could be used to investigate the contracture across different cell
types.
The majority of tissue structures were cultured by basal medium supplemented with
an animal-derived serum that is not chemical-defined culture condition. This adds unknown
factors for fabrication and analysis since animal serum has batch-to-batch variation leading to
inconsistency results48 and unplanned interactions with the test subjects49,50. Furthermore,
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tissues cultured with animal-derived serum could be exposed to the risk of (virus, bacterial,
and fungal) contamination51,52. This risk would be eliminated if serum-free media is used.
The serum also contains a large amount of high molecular weight protein, which is an
uncommon environment for somatic cells53. Thus, chemical-defined culture media has been
chosen to fabricate hiPSC-MSC rings resulting in geometrical consistency and high
reproducibility.
Tissues with different shapes have been fabricated from the multi-post system, which
could be an important tool to observe and study matrix remodeling and cell contractility. Our
previously described structures fabricated from 2-post oval and 4-post triangle gaps
remodeling in contrast manner; the 2-post shapes remodeled to the direction of the post, but
the 4-post shapes remodeled in opposite direction to the posts. Yet, the deflection of these
two shapes progressed in the same inward direction.
Similar matrix remodeling study has been done with cardiac cells within
collagen/fibrin 3D matrices in PDMS well platform containing 2 cantilevers on each side to
fabricate dog-bone tissue shapes54. Dog-bone tissue shapes width changes had been observed
over time and were explained by current stress comparing to maximum contractile stress
(stall stress) of the cells vs strain rate relation which is like that of a sarcomere. The
contractile stress was occurred at the junction between each adherent cell and its substrate
and measured with traction microscopy55. Shortly, in any portion of tissue shape, if the
portion receives the stress more than the stall stress, that portion will extend in the same axis
of the stress and in turn narrowing that portion, and vice versa. The stress could be calculated
from the static force from cantilevers and cross-sectional area of the tissue shape. The static
force was derived from stiffness and deflection of the cantilevers, while cross-sectional areas
were measured visually. Increasing cantilever stiffness would increase tissue tension and
stress54,56. Matrix stiffness also affects the amount of stress56; the denser the matrix, the lesser
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the stress. Surprisingly, An attempt to temporary stiffen the cantilever by attaching magnetic
bead on the posts and using a magnetic field to counter the bending were resulted in
increasing cell contractility of valvular interstitial cells57. The strain rate could be quantified
by tracking the deformation on each point of the tissue shape visually. The maximal principle
stress direction affecting cell tension was another remodeling direction indicator as the nuclei
aligned to the direction58.
Expanding from dog-bone shape to other shapes, Schell et al discovered that Matrix
geometry influencing maximal principle stress directions, and in turn cell tension as observed
by the nucleus directions which aligned to the directions58. Agarose hydrogel molds with
different geometry, number, and position of agarose posts were seeded with chondrocytes and
fibroblasts and used to predict the maximal principle stress directions via finite element
method by treating the tissue as neo-Hookean material and the posts as a rigid body. The
predicted stress directions were aligned to the nucleus directions. For instance, hexagonal
equibiaxial shapes had the equal nucleus directions in every direction in the center as
predicted by the calculation as do the dog-bone shapes in the rod section, which were
predicted to have mostly horizontal stress directions. Both cell types had the same nucleus
directions according to the mold design but the fibroblast tissue shapes, especially dog-bone
shapes, were more deflected and elongated than the chondrocytes tissue shapes since
fibroblasts are more contractile.
The matrix remodeling also affects cell contractility59. The matrix with and without
cells under magnetic force was compared and shown that the matrix with cells returned its
former stress and strain values before the force was applied, while the matrix without cells
did not have the same recovery ability. Polacheck and Chen explored further and found that
the deflection of the posts/cantilevers were from the combination of cells generated forces
within the tissue60. With these concepts, we could explore the relation behind the matrix
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remodeling and cell contractility using different tissue shapes by modifying post position and
quantity, mechanical forces by varying matrix stiffness, cell types, post stiffness, and likely
size.
To further characterize the tissue morphology, the tissue height and volume will need
to be measured and calculated. We have encountered some difficulties to measure the height
directly through actin staining and upright confocal microscope, since the standing posts will
interfere lowering down the objective for imaging the bottom of the tissues. A potential
approach to measure the height can be completed by cutting the mold boundary and
visualized sideway, which will sacrifice the PDMS molds. The tissue volume could be
estimated based on the height and area measurements.
To measure the mechanical properties of the tissue rings, the rings would be mounted
on tensile testing machine such as Instron EPS 1000 in the horizontal position and attached
on load cell of 1N ±1mN and custom wire grips32. The rings would be extended to tare load
and recorded for the gauge length. After entering cross-sectional area of the rings calculated
from tissue thickness, stress-strain curve would be ready to be plotted. Appropriate amount of
pre-cycling would be performed, and the rings would be pull to failure. Ultimate tensile
strength and fracture strength would be recorded, and elastic modulus would be calculated
from the stress-strain curve.
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5.

Appendix

Table 1. Measurement of fibroblast rings cultured with 2.0 mg/ml collagen density using
mixing protocol in Pluronic-coated wells.
Ring Diameter
(mm)
3.90 ± 0.42
3.61 ± 0.12
3.58 ± 0.20
3.51 ± 0.12
3.49 ± 0.13
3.52 ± 0.06

Day
1
2
4
7
10
14

Thickness
(mm)
1.04 ± 0.22
1.08 ± 0.12
1.12 ± 0.12
1.13 ± 0.18
1.10 ± 0.14
1.11 ± 0.10

Inner
Diameter
(mm)
1.82 ± 0.11
1.46 ± 0.17
1.35 ± 0.11
1.26 ± 0.26
1.28 ± 0.19
1.30 ± 0.18

n
6
6
6
6
6
6

Table 2. Measurement of hiPSC-MSC rings with different collagen density.
Collagen
(mg/ml)
0.5
1.0
2.0

Density Thickness
(mm)
0.92 ± 0.08
0.50 ± 0.19
0.73 ± 0.08

Inner Diameter
(mm)
2.37 ± 0.35
2.65 ± 0.44
1.59 ± 0.21

Ring Diameter
(mm)
3.34 ± 0.42
3.08 ± 0.29
2.26 ± 0.31

n
5
5
4

Table 3. Measurement of hiPSC-MSC rings with different cell seeding number and
serum concentration.
Cell Number
10% FBS
5% FBS
Serum-free
Cell Number
10% FBS
5% FBS
Serum-free

300,000
Thickness (mm)
0.58 ± 0.03
0.64 ± 0.08
0.58 ± 0.07
600,000
Thickness (mm)
0.68 ± 0.13
0.59 ± 0.07
0.77 ± 0.32

Inner Diameter (mm)
1.34 ± 0.17
1.81 ± 0.8
13 ± 0.17

Ring Diameter (mm)
2.50 ± 0.10
3.09 ± 0.09
2.5 ± 0.04

n
5
5
4

Inner Diameter (mm)
1.73 ± 0.26
1.42 ± 0.55
1.06 ± 0.11

Ring Diameter (mm)
3.10 ± 0.36
2.60 ± 0.56
2.59 ± 0.63

n
5
4
5
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Table 4. Measurement of hiPSC-MSC triangles.
(nG = normalized gap, nD = normalized deflection).
6 mm without cp

8 mm

8 mm without cp

N

7

4

3

Day

nG

Nd

nG

nD

nG

nD

1

0.16 ± 0.01

0.00 ± 0.02

0.14 ± 0.02

0.04 ± 0.01

0.15 ± 0.03

0.03 ± 0.01

3

0.16 ± 0.01

0.00 ± 0.01

0.13 ± 0.01

0.02 ± 0.01

0.15 ± 0.04

0.02 ± 0.00

5

0.16 ± 0.01

0.00 ± 0.01

0.14 ± 0.01

0.03 ± 0.01

0.16 ± 0.02

0.03 ± 0.01

7

0.19 ± 0.02

0.01 ± 0.01

0.17 ± 0.01

0.05 ± 0.01

0.18 ± 0.02

0.05 ± 0.01

9

0.21 ± 0.04

0.04 ± 0.01

0.20 ± 0.03

0.07 ± 0.02

0.26 ± 0.05

0.08 ± 0.00

11

0.22 ± 0.04

0.05 ± 0.02

0.21 ± 0.03

0.09 ± 0.02

0.30 ± 0.02

0.10 ± 0.01

13

0.23 ± 0.03

0.06 ± 0.02

0.22 ± 0.03

0.11 ± 0.02

0.31 ± 0.02

0.11 ± 0.01
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